{"success":true,"data":{"pressRelease":{"id":"168848","rtpr_id":"nGNX2S9Qk7-20261014","ticker":"CAMP","exchange":"NASDAQ","all_tickers":["CAMP"],"title":"CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference","author":"Globe Newswire","published_at":"2026-10-14T12:00:03.236Z","article_body":"WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics\nCorporation\n(https://www.globenewswire.com/Tracker?data=xH299NAJYzucpFTlnzQmITPNuS50FtjlMX_T6CNzYIzPP8fV5guk1iDwnfDSSgN3y24Zbf7xBzvHnVwD2APUkN8tmHDd9Xq0-X_a8RdFZkE5fT7D_5xSKqs6iI8IGP_E)\n(“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company\ndeveloping a pipeline of regulatory RNA-targeting therapeutics designed to\nupregulate gene expression with the goal of restoring healthy protein levels\nto treat a broad range of genetic diseases, today announced that the company\nwill participate in a panel during Chardan’s 10(th) Annual Healthcare\nConference on October 20, 2026. Details below:\n\nChardan’s 10(th) Annual Healthcare Conference\n\n Title          RNA Medicines: Transcriptome Engineering                                                                                                                                                                                                                                                                                                                            \n Format         Panel                                                                                                                                                                                                                                                                                                                                                               \n Date and Time  October 20, 2026 | 9:15-9:45 a.m. EDT                                                                                                                                                                                                                                                                                                                               \n Location       New York, NY                                                                                                                                                                                                                                                                                                                                                        \n Webcast link   Click Here (https://urldefense.proofpoint.com/v2/url?u=https-3A__event.summitcast.com_view_nUJwqi8DxFcP2EqRxm6gQf_esNCurgknZ3d3FieYyFKKT&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=tu3Fo1NplWEzzoehBsjlHOyK7pbpLpr3gQGSfNmfQ5c&m=bVKd-ae-tTdGGQZnnHXVd8TfYPQ75mQp04HRmR3mU9JWJKVd7Hz87PEO8044EIeU&s=8moV9oqVJWb2VN_-YOyzUOBckpkWrpeYqeuyC7iCmaA&e=)  \n                                                                                                                                                                                                                                                                                                                                                                                    \n\nThe event will be webcast and can be accessed on the investor relations page\nof CAMP4’s website at www.investors.camp4tx.com. A replay of the webcast\nwill be archived on the CAMP4 website for 30 days following the conference.\n\nAbout CAMP4 Therapeutics\nCAMP4 is developing disease-modifying treatments for a broad range of genetic\ndiseases where amplifying healthy protein may offer therapeutic benefits. Our\napproach amplifies mRNA by harnessing a fundamental mechanism of how genes are\ncontrolled. To amplify mRNA, our therapeutic ASO drug candidates target\nregulatory RNAs (regRNAs), which act locally on transcription factors and are\nthe master regulators of gene expression. CAMP4’s proprietary RAP\nPlatform(®) enables the mapping of regRNAs and generation of therapeutic\ncandidates designed to target the regRNAs associated with genes underlying\nhaploinsufficient and recessive partial loss-of-function disorders, of which\nthere are more than 1,200, in which a modest increase in protein expression\nmay have the potential to be clinically meaningful. For more information,\nvisit camp4tx.com\n(https://www.globenewswire.com/Tracker?data=io_d9T7Inj904WqZtKqHvDWp4FFZOmE64x9sWgawkT0DMH9BwOOWuYzYev_LrNHEo2bQtcXerOjL312yR2RxdB1FkysE4yvtFD6hwg48oMpSVdymVkQ2LUmasgWteN0WqollSWuuYjXMMIgc4yLTG2300kbzkTCSlv5YPS7O3_fjnSRD5JRElfGCLpar2JCN3byTEM7KZmDf-bBPjOpEqczerjka-VA0NZ41F06DXc4=).\n\nContacts\n\nInvestor Relations:\nSara Michelmore\nMilestone Advisors\nsara@milestone-advisorsllc.com\n\nMedia:\nSofia Bermudez\nLifeSci Communications\nsbermudez@lifescicomms.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX2S9Qk7-20261014","title":"CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference","author":"Globe Newswire","ticker":"CAMP","created":"2026-10-14T12:00:03.236Z","tickers":["CAMP"],"exchange":"NASDAQ","article_body":"WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics\nCorporation\n(https://www.globenewswire.com/Tracker?data=xH299NAJYzucpFTlnzQmITPNuS50FtjlMX_T6CNzYIzPP8fV5guk1iDwnfDSSgN3y24Zbf7xBzvHnVwD2APUkN8tmHDd9Xq0-X_a8RdFZkE5fT7D_5xSKqs6iI8IGP_E)\n(“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company\ndeveloping a pipeline of regulatory RNA-targeting therapeutics designed to\nupregulate gene expression with the goal of restoring healthy protein levels\nto treat a broad range of genetic diseases, today announced that the company\nwill participate in a panel during Chardan’s 10(th) Annual Healthcare\nConference on October 20, 2026. Details below:\n\nChardan’s 10(th) Annual Healthcare Conference\n\n Title          RNA Medicines: Transcriptome Engineering                                                                                                                                                                                                                                                                                                                            \n Format         Panel                                                                                                                                                                                                                                                                                                                                                               \n Date and Time  October 20, 2026 | 9:15-9:45 a.m. EDT                                                                                                                                                                                                                                                                                                                               \n Location       New York, NY                                                                                                                                                                                                                                                                                                                                                        \n Webcast link   Click Here (https://urldefense.proofpoint.com/v2/url?u=https-3A__event.summitcast.com_view_nUJwqi8DxFcP2EqRxm6gQf_esNCurgknZ3d3FieYyFKKT&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=tu3Fo1NplWEzzoehBsjlHOyK7pbpLpr3gQGSfNmfQ5c&m=bVKd-ae-tTdGGQZnnHXVd8TfYPQ75mQp04HRmR3mU9JWJKVd7Hz87PEO8044EIeU&s=8moV9oqVJWb2VN_-YOyzUOBckpkWrpeYqeuyC7iCmaA&e=)  \n                                                                                                                                                                                                                                                                                                                                                                                    \n\nThe event will be webcast and can be accessed on the investor relations page\nof CAMP4’s website at www.investors.camp4tx.com. A replay of the webcast\nwill be archived on the CAMP4 website for 30 days following the conference.\n\nAbout CAMP4 Therapeutics\nCAMP4 is developing disease-modifying treatments for a broad range of genetic\ndiseases where amplifying healthy protein may offer therapeutic benefits. Our\napproach amplifies mRNA by harnessing a fundamental mechanism of how genes are\ncontrolled. To amplify mRNA, our therapeutic ASO drug candidates target\nregulatory RNAs (regRNAs), which act locally on transcription factors and are\nthe master regulators of gene expression. CAMP4’s proprietary RAP\nPlatform(®) enables the mapping of regRNAs and generation of therapeutic\ncandidates designed to target the regRNAs associated with genes underlying\nhaploinsufficient and recessive partial loss-of-function disorders, of which\nthere are more than 1,200, in which a modest increase in protein expression\nmay have the potential to be clinically meaningful. For more information,\nvisit camp4tx.com\n(https://www.globenewswire.com/Tracker?data=io_d9T7Inj904WqZtKqHvDWp4FFZOmE64x9sWgawkT0DMH9BwOOWuYzYev_LrNHEo2bQtcXerOjL312yR2RxdB1FkysE4yvtFD6hwg48oMpSVdymVkQ2LUmasgWteN0WqollSWuuYjXMMIgc4yLTG2300kbzkTCSlv5YPS7O3_fjnSRD5JRElfGCLpar2JCN3byTEM7KZmDf-bBPjOpEqczerjka-VA0NZ41F06DXc4=).\n\nContacts\n\nInvestor Relations:\nSara Michelmore\nMilestone Advisors\nsara@milestone-advisorsllc.com\n\nMedia:\nSofia Bermudez\nLifeSci Communications\nsbermudez@lifescicomms.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-14T12:00:03.546353516Z","server_sent_at_ms":1791979203546},"received_at":"2026-10-14T12:00:03.596Z","source_url":null},"analysis":{"id":"157098","press_release_id":"168848","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"CAMP4 Therapeutics will participate in a panel titled 'RNA Medicines: Transcriptome Engineering' at Chardan's 10th Annual Healthcare Conference on October 20, 2026, in New York.\n\nThe panel runs 9:15-9:45 a.m. EDT and will be webcast, with a replay archived on CAMP4's investor relations site for 30 days.\n\nThis is a scheduling notice only, with no new clinical, financial, or regulatory information disclosed.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference appearance -- suppress unless panel reveals new pipeline data."},"keyFigures":{},"namedEntities":{"people":[],"products":["RAP Platform"],"companies":[{"name":"CAMP4 Therapeutics Corporation","ticker":"CAMP","relationship":"filer"},{"name":"Chardan","relationship":"conference host"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Conference participation notice with no new data, results, or guidance. Routine IR scheduling announcement."},"tickerRelevance":{"others":[],"primary":"CAMP"},"globalImportance":5,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"conference-participation-notice","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"CAMP4 Therapeutics will participate in a panel titled 'RNA Medicines: Transcriptome Engineering' at Chardan's 10th Annual Healthcare Conference on October 20, 2026, in New York.\n\nThe panel runs 9:15-9:45 a.m. EDT and will be webcast, with a replay archived on CAMP4's investor relations site for 30 days.\n\nThis is a scheduling notice only, with no new clinical, financial, or regulatory information disclosed.","key_figures":{},"named_entities":{"people":[],"products":["RAP Platform"],"companies":[{"name":"CAMP4 Therapeutics Corporation","ticker":"CAMP","relationship":"filer"},{"name":"Chardan","relationship":"conference host"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-14T12:00:31.552Z","global_importance":5,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"conference-participation-notice","issuerAuthored":true}},"durationMs":4013,"modelName":"glm-5.3-flashx"}}